Keyword: Valeant

News

Ackman Buys More Valeant Shares

23.10.2015 - Hedge fund manager and activist shareholder Bill Ackman has bought 2 million new shares in Valeant at an estimated total cost of $230 million. The buy is said to have increased his...

News

Valeant under Pressure From US Legislators

30.09.2015 - Shares of US-listed Canadian drugmaker Valeant came under additional severe pressure early this week when Democratic party members on the House of Representative committee on...

News

Valeant Teams with AstraZeneca on Psoriasis

04.09.2015 - Canadian drugmaker Valeant has said it will work with AstraZeneca on a potential treatment for psoriasis, brodalumab, taking up the gauntlet from Amgen, which recently curtailed...

News

Valeant to Acquire Sprout and Enter Sexual Health Market

24.08.2015 - US specialty drugs company Valeant Pharmaceuticals has agreed to pay $1 billion in cash, on a debt-free basis, for female sexual heath firm Sprout Pharmaceuticals. Under the terms...

News

Mylan Said to Prepare Poison Pill Potion Against Teva

24.04.2015 - US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...

News

Valeant Wins Battle for Salix Pharmaceuticals

17.03.2015 - Valeant Pharmaceuticals increased its takeover offer for Salix Pharmaceuticals to $10.96 billion in cash, eliminating Endo International, the only other bidder. Salix has agreed to...

News

Endo International Tries to Spoil Valeant’s Salix Deal

16.03.2015 - Dublin, Ireland-based Endo International has made a takeover bid for US drugmaker Salix Pharmaceuticals in an effort to thwart Valeant Pharmaceuticals International's $10 billion...

News

Actavis Changing Name to Allergan

19.02.2015 - Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...